Herrera-Ortiz A, Arriaga-Demeza CR, Conde-González CJ, Sánchez-Alemán MÁ

Language: Spanish
References: 36
Page: 16-26
PDF size: 702.56 Kb.

ABSTRACT

Introduction: herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV) are the most frequent sexually transmitted infections (STI) among college students 18-24 years old. Educational interventions for STI prevention can help to decrease viral STI prevalence among students. Objective: to know the change in knowledge, perception of risk and sexual behavior among 182 students of the Autonomous University of the State of Morelos. Material and method: a community intervention trial (before-after) was carried out, using brochures for prevention of HSV-2 and HPV, including information about these STI, with emphasis on the risk factors identified in students of the same university. Results: we found a change in the perception of STI risk during the intervention (56.5 before vs. 67.7% after intervention), possibly the brochures assisted students to learn more about their own risk behaviors. Likewise, there was an increase in knowledge in both HPV and HSV-2. Conclusions: it is necessary to increase the sample size in future interventions to assess further the change in knowledge, sexual behaviors and the prevalence of infections.

REFERENCES

1. Bernal-Alcántara B, Hernández-Tepichin G. Las enfermedades de transmisión sexual ETS: otro reto para la prevención y control de la epidemia del VIH/SIDA. SIDA-ETS. 1997;3:63-7.

2. Center for Disease Control and Prevention. Morbidity and Mortality weekly. Recommendations and reports. Sexually Transmitted Diseases Treatment Guideliness U.S. Department of Health and Human Services. Atlanta, GA: CDC; 2002;51:1-80.

3. OMS. Estrategia mundial de prevención y control de las infecciones de transmisión sexual 2006-2015. Ginebra, 2007.

4. Cameron DW, Simonsen JN, D’Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989;2:403-7.

5. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28: 579-97.

6. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45-52.

7. Fox J, Fidler S. A comprehensive recent review of determinants of sexual transmission of HIV. Sexual transmission of HIV-1. Antiviral Res. 2010;85:276-85.

8. Ward H, Rönn M. The contribution of STIs to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:305-10.

9. SINAVE. Manual de procedimientos de la notificación semanal de casos nuevos. Casos sujetos a notificación obligatoria. 2006.

10. SINAVE/DGE/Salud/Sistema de notificación semanal de casos nuevos/Acceso al cierre de 2010.

11. Uribe-Salas F, Palma-Coca O, Sánchez-Alemán MA, Olamendi M, Juárez-Figueroa L, Conde-González CJ. Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico. Trans R Soc Trop Med Hyg. 2009;103: 151-8.

12. Conde-González C, Lazcano-Ponce E, Hernández-Girón C, Juárez-Figueroa L, Smith JS, Hernández-Ávila M. Seroprevalencia de la infección por el virus herpes simple tipo 2 en tres grupos poblacionales de la ciudad de México. Salud Pub Mex. 2003;45:608-16.

13. Uribe F, Conde C, Juárez L, Hernández-Castellanos A. Socio-demographic characteristics and sex practices related to herpes simplex virus type 2 infection in Mexican and Central American female sex workers. Epidemiol Infect. 2003;131:859-65.

14. Dimitry Abraham C, Conde González C, Cruz Valdez A, Sánchez-Zamorano L, Hernández-Márquez CI, Lazcano-Ponce E. Sexual and demographic risk factors for herpes simplex virus type 2 according to schooling level among Mexican youths. Sex Transm Di. 2003;30:549-55.

15. Gutiérrez J, Bertozzi S, Conde C, Sánchez-Alemán MA. Risk behavior of 15-21 year olds in Mexico lead to a high prevalence of sexually transmitted infections: results of a survey in disadvantage urban areas. BMC Public Health. 2006;6:49-61.

16. Lazcano-Ponce E, Herrero R, Muñoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412-20.

17. Juárez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, Conde-González CJ, Zamilpa-Mejía LG, García-Cisneros S. Human papillomavirus, a highly prevalent sexually transmitted disease among female sex workers from Mexico City. Sex Transm Dis. 2001;28:125-30.

18. Sánchez-Alemán MA, Uribe-Salas F, Conde-González CJ. La infección por el virus del papiloma humano, un posible marcador biológico de comportamiento sexual en estudiantes universitarios. Salud Pub Mex. 2002;44:442-7.

19. Sánchez M, Conde C, Gayet C, García-Cisneros S, Uribe-Salas F. Sexual behavior and herpes simplex virus 2 infection in college students. Arch Med Res. 2005;36:574-80.

20. Dorantes-Peña HG, Uribe-Salas FJ, García-Cisneros S, Olamendi-Portugal ML, Conde-González CJ, Sánchez-Alemán MA. Prevalencia y factores asociados a las infecciones por Chlamydia trachomatis y Neisseria gonorrhoeae en estudiantes de la Universidad Autónoma del Estado de Morelos. Enf Inf Microbiol. 2011;31:46-51.

21. Torres P, Walker MD, Gutiérrez JP, Bertozzi SM. Estrategias novedosas de prevención de embarazo e ITS/VIH/SIDA entre adolescentes escolarizados mexicanos. Salud Pub Mex. 2006;48:308-16.

22. Gayet C, Juárez F, Pedrosa L. Uso del condón entre adolescentes mexicanos para la prevención de las infecciones de transmisión sexual. Salud Pub Mex. 2003;45(Suppl):632-40.

23. Del Río-Chiriboga C, Uribe P. Prevención de enfermedades de transmisión sexual y SIDA mediante el uso del condón. Salud Pub Mex. 1993;35:508-17.

24. Elwy A, Hart GJ, Hawkes S, Petticrew M. Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men. Arch Intern Med. 2002;162:1818-30.

25. Manhart L, Holmes K. Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked? J Infect Dis. 2005;191(Suppl): 7-24.

26. Zhang J, Yu KF. What’s the relative risk?: a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280: 1690-1.

27. Pérez G, Lazcano-Ponce E, Hernández-Ávila M, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle. Vaccine in Latin American women. Int J Cancer. 2008;122:1311-8.

28. Reynales-Shigematsu LM, Rodrigues ER, Lazcano-Ponce E. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico. Arch Med Res. 2009;40:503-13.

29. Flores Y, Shah K, Lazcano E, et al. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV study. Salud Pub Mex. 2002;44:335-44.

30. Salmerón J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPVbased assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes & Control. 2003;14:505-12.

31. Vogtmann E, Harlow SD, Cruz-Valdez A, Cruz-Valdez JC, Lazcano-Ponce E. HPV knowledge in Mexican college students: implications for intervention programmes. Health Soc Care Community. 2011;19:148-57.

32. Gaviria A. Conocimientos de los estudiantes universitarios del Colegio Mayor de Antioquía, Medellín acerca del papilomavirus humano. Revista Facultad Nacional de Salud Pública. 2003;21:43-8.

33. Lenselink CH, Schmeink CE, Melchers WJ, et al. Young adults and acceptance of the human papillomavirus vaccine. Public Health. 2008;122:1295-301.

34. Lambert EC. College students’ knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001;14:178-83.

35. Argüero L, Castañeda A, Hernández G, Duran DA. Virus del papiloma humano. Lo que saben estudiantes masculinos de licenciatura. Rev Med IMSS. 2004;42:321-6.

36. Dell D, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents. Obstet Gynecol. 2000;96:653-6.